MoS launches BIO-NIVESH to Catalyse Investment and Scale-Up of Biotechnology Innovations (See 'Corp Brief') NTPC Electron Quiz 2026-27 to be held in Mumbai (See 'Corp Brief') SUMAN Roadmap 2030 focuses on 13 High-Focus States to reduce Maternal and Newborn Deaths (See 'Corp Brief') Media Registration Open for SEMICON India 2026 (See 'Corp Brief') CCI directs IDBI Trusteeship, Axis Trustee and SBI CAP Trustee to cease and desist from anti-competitive conduct (See 'Corp Brief') Environment Minister reviews Coordinated Efforts by NCR States to tackle Air Pollution (See 'Corp Brief') CPC - Objection regarding pecuniary jurisdiction cannot be entertained at stage of final arguments when no such objection is raised by defendant at earliest opportunity or before settlement of issues: HC (See 'Legal Desk') Nadda inaugurates Centre for Advanced Bladder Diagnostics (See 'Corp Brief') NIELIT and Intel India launch Agentic AI Skilling Programs (See 'Corp Brief') IBC - IRP has contravened statutory mandate of IBC by omitting to maintain formal minutes of meetings & relying instead on informal email communications & where IRP omits to act strictly as per prior instructions of CoC: IBBI (See 'Legal Desk') BRICS Members reaffirm Commitment for Multilateral Cooperation in Intellectual Property (See 'Corp Brief') Digital India BHASHINI and Kathmandu Univ explore Collaboration in Language AI (See 'Corp Brief') IBCA, ADB sign MoU strengthening collaboration in Landscape Conservation (See 'Corp Brief') EPFO seeks applications from potential beneficiaries (See 'Corp Brief') IPR - For deciding territorial jurisdiction at inception of suit, if plaintiff's pleadings sufficiently allege that defendant has digital presence accessible, suit cannot be summarily thrown out for lack of jurisdiction: HC (See 'Legal Desk') CCI okays acquisition of up to 100% equity of Apollo Fertility & Apollo Specialty by Kids Clinic India (See 'Corp Brief') CCI approves acquisition of Aseem Infra Finance by TPG Nicobar SG (See 'Corp Brief') Ministry of Civil Aviation launches Hub & Spoke International Flight Operations (See 'Corp Brief') CAQM reviews Enforcement Actions (See 'Corp Brief') IBC - Definition of 'associate' u/s 79(2)(g) cannot be expanded beyond its statutory text, and procedural irregularities such as absence of forensic audit do not warrant rejection if no actual prejudice is demonstrated: NCLT (See 'Legal Desk') Wow! 7.8% growth but it also does not reveal many things! (See CORP EINSICHT) India, Germany sign Joint Declaration of Intent on environment conservation (See 'Corp Brief') IBC - If foreign decree from reciprocating territory remains substantially unsatisfied, and judgment debtor and his family exercise pervasive control over multiple business entities, decree holder is entitled to protection of its interest through appropriate security: SC LB (See 'Legal Desk') Advisor to PM reviews Development Initiatives at Belgaria and Karmatand Townships (See 'Corp Brief') Invest in R&D while fostering partnerships to become global enterprises: RM (See 'Corp Brief') SARFAESI - Attachment of entire subject property cannot be sustained in absence of material showing direct nexus between property & investors' funds involved in criminal proceedings: HC (See 'Legal Desk') Ministry of Coal Holds Preparatory Meeting for Special Campaign 6.0, Reaffirms Commitment to Cleanliness and Efficiency (See 'Corp Brief') PBPT - Per Section 2(26), initiating officer must establish that benami amount was either converted into another form or integrated into general business assets of beneficial owner beyond demarcation before attaching substitute properties: Tribunal (See 'Legal Desk') India must build Future-Ready Workforce for a Global Automotive Industry: Kumaraswamy (See 'Corp Brief') Union Minister to launch fisheries Infrastructure projects worth Rs 36.49 Crore (See 'Corp Brief') Nadda reviews Progress of Rural Health Training Centre, Najafgarh (See 'Corp Brief') IPR - If plaintiff holds registered trademark rights and shows prima facie prior adoption and use, defendant's use of identical mark for identical hospitality & restaurant services is sufficient to justify interim injunctive relief: HC (See 'Legal Desk') 4th Indo-German Environment Forum to be held in New Delhi (See 'Corp Brief') ICAR-IIOR to host Industry Interface to Accelerate Commercialization of Oilseed Technologies (See 'Corp Brief') A&C - Arbitral award immune to interference merely because alternative interpretation of facts or contractual terms exists; cannot be quashed where award is plausible, logical & free from patent illegality, perversity, or conflict with public policy: HC (See 'Legal Desk') Manohar Lal directs Fast-track Project Implementation & Strengthening of Swachhata (See 'Corp Brief') MSDE in collaboration with UP Govt organises PM-SETU Industry Conclave in Lucknow (See 'Corp Brief') MoS holds interaction with delegation of Armed Forces HQ Association (See 'Corp Brief') NBA disburses Rs 5.68 Crore in Benefit-Sharing Funds for Biodiversity Conservation (See 'Corp Brief') Commerce Secretary Rajesh Agrawal Leads 4th India-Argentina JTC Meeting (See 'Corp Brief') IBC - Sale certificate issued by liquidator under insolvency proceedings in respect of property sold by public auction is not compulsorily registrable: HC (See 'Legal Desk') CBN seizes 66.80 lakh psychotropic tablets in major inter-state pharmaceutical diversion case (See 'Corp Brief') Acquire knowledge, question injustice through constitutional means: RM tells youth (See 'Corp Brief') Empowering mother can enable early identification of disability in child: MoS (See 'Corp Brief') MoS lays Foundation Stone of PMGSY Roads Worth Rs 1,503 Crore in Jammu (See 'Corp Brief') Companies Act - Corporate name change is merely alteration of MoA that preserves company's continuous legal identity, rights, liabilities & obligations without creating a new entity or dissolving the old one: HC (See 'Legal Desk')

MoS launches BIO-NIVESH to Catalyse Investment and Scale-Up of Biotechnology Innovations

Published: Sep 05, 2026

By TIOLCorplaws News Service

NEW DELHI, SEP 05, 2026: UNION Minister of State (Independent Charge) for Science & Technology and Earth Sciences, and Minister of State, PMO, Personnel, Public Grievances & Pensions, Atomic Energy and Space, Dr. Jitendra Singh thursday held a joint round table with StartUps and Investors, and also launched BIO-NIVESH, a strategic platform aimed at strengthening engagement between biotechnology innovators and the investment community and catalysing the flow of private capital into promising biotechnology innovations for scale-up and commercialisation.

Dr. Jitendra Singh said innovation is incomplete without investment, while investment will not sustain itself without innovation, making closer engagement between innovators, investors, industry and Government essential for India's biotechnology-led growth. He said BIO-NIVESH would help build the bridge required to take promising ideas from research and entrepreneurship to industry, scale and markets.

During the interactive roundtable with participating startups and investors at BIO-NIVESH, Dr. Jitendra Singh suggested that the biotechnology ecosystem could consider the feasibility of a “Big Five in Five Years” approach. Referring to a similar idea discussed at a recent roundtable with space investors and entrepreneurs, he said focused resources for creating a few large anchor companies could help build an ecosystem under whose shadow other startups could also grow and expand. He said ideas emerging from one sector could be examined for their applicability in another, wherever feasible.

The Minister said the objective should be to create an ecosystem in which science meets capital, innovation meets industry and research meets the market. He said the Government can create enabling conditions and take the initial risk, but private capital has a critical role in sustaining growth, building enterprises and taking technologies to scale.

Dr. Jitendra Singh said biotechnology could drive the next industrial revolution and India must not repeat the experience of being a late entrant, as happened during the IT revolution when the country was about a decade behind. He said initiatives such as BIO-NIVESH are aimed at ensuring that India is prepared to capture the opportunities emerging from the next wave of technology-led growth.

The Minister said the BIO-NIVESH approach reflects the Government's broader “whole of government plus whole of nation” approach, as biotechnology innovation and investment require coordination across multiple ministries and sectors. He congratulated BIRAC and the team behind BIO-NIVESH for bringing together diverse stakeholders and pursuing an agenda that extends beyond the Department of Biotechnology alone.

Drawing on the experience of recent policy initiatives, Dr. Jitendra Singh said the opening up of the space sector to private participation had generated significant interest among investors and entrepreneurs. He also referred to the opening up of the nuclear sector to private players, saying that the policy announcement itself generated strong investment interest, including from international business leaders. He said such experiences demonstrate how enabling policy decisions can create an appetite for investment even in sectors where private participation was earlier limited.

On biotechnology, the Minister called for greater engagement with the corporate sector and a change of mindset on both sides. He said biotechnology has its own characteristics, with longer development cycles, demanding regulatory pathways and significant capital requirements, while successful innovations can generate enduring value and major impact on health, society and the economy.

The Minister invited investors to look beyond immediate funding rounds and assess the technology, intellectual property, development pathway, market potential and possibility of building globally competitive companies from India. He also encouraged innovators to engage with investors early, noting that the right investor can bring not only capital but also strategic knowledge, partnerships, manufacturing capabilities, market access and global networks.

Dr. Jitendra Singh said India's rapidly expanding bioeconomy demonstrates the potential of its young scientists, entrepreneurs and innovation ecosystem. He said the next phase must ensure that promising biotechnology innovations receive the capital, partnerships and market access needed to move from laboratory to scale and from scale to global markets.

He said public funding alone cannot take every promising innovation to market and scale, and that Government support should serve a catalytic purpose by reducing early-stage risk, demonstrating technological potential and making innovations more investable for private capital.

The Minister also referred to the Research, Development and Innovation (RDI) Fund with an outlay of ?1 lakh crore, under which BIRAC has been designated as a Second-Level Fund Manager for biotechnology and allied sectors. He said the framework would enable long-term patient capital for technology developers, startups and companies working in strategic biotechnology domains, particularly projects ready for technology translation, scale-up and innovation-led manufacturing.

The inaugural edition of BIO-NIVESH brought together 20 high-potential biotechnology/deep-tech startups and a curated group of around 50 investors. The platform has been designed as a two-way engagement mechanism going beyond conventional startup pitching or investor-connect formats, enabling innovators to understand the investment lens while giving investors deeper insight into the scientific, regulatory and development pathways of biotechnology.

The first session featured direct Startup–Investor Connect, with the 20 startups selected on the basis of innovation, development stage, market potential, scalability and regulatory readiness. The second session featured an interactive engagement of the Minister with participating investors and startups on access to capital, commercialisation, scale-up and enabling measures for innovation-led growth.

The programme was attended by Dr. Rajesh S. Gokhale, Secretary, Department of Biotechnology, DG-BRIC and Chairman, BIRAC; Dr. Dhananjay Tiwary, Senior Advisor, DBT and Managing Director, BIRAC; Prashant Prakash, Founding Partner, Accel India; along with representatives of the investor and startup communities.

Dr. Jitendra Singh said BIO-NIVESH should ultimately be judged not by the number of pitches or meetings, but by the partnerships created, investments mobilised, technologies scaled and products brought to market. He expressed confidence that the platform would become an important strategic mechanism for strengthening India's innovation-investment interface and enabling biotechnology innovations to move from laboratory to market and from India to the world.

BIO-NIVESH is envisaged as a recurring platform, with subsequent editions proposed across different cities to broaden participation, connect regional biotechnology innovation ecosystems with investment networks and build sustained engagement between innovators and investors.

TIOL CORP SEARCH

TIOL GROUP WEBSITES